{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:09:49Z","timestamp":1792174189772,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.rbmo.2017.06.018","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T13:01:14Z","timestamp":1499086874000},"page":"461-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss"],"prefix":"10.1016","volume":"35","author":[{"given":"Amihai","family":"Rottenstreich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagai","family":"Amsalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geffen","family":"Kleinstern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Kalish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2017.06.018_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0020-7292(02)00197-2","article-title":"ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists","volume":"78","author":"ACOG","year":"2002","journal-title":"Int. J. Gynaecol. Obstet"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0015","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3349\/ymj.2016.57.5.1230","article-title":"The impact of inherited thrombophilia types and low molecular weight heparin treatment on pregnancy complications in women with previous adverse outcome","volume":"57","author":"Aracic","year":"2016","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.rbmo.2017.06.018_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.fertnstert.2012.09.023","article-title":"Practice Committee. Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"99","author":"ASRM","year":"2013","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0025","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMcp1005330","article-title":"Clinical practice. Recurrent miscarriage","volume":"363","author":"Branch","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","article-title":"Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study","volume":"3","author":"Brenner","year":"2005","journal-title":"J. Thromb. Haemost"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0035","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/humrep\/14.11.2868","article-title":"A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage","volume":"14","author":"Brigham","year":"1999","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0040","author":"Choosing Wisely Canada"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0045","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1182\/blood-2010-01-267252","article-title":"Scottish Pregnancy Intervention Study (SPIN) collaborators, 2010. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage","volume":"115","author":"Clark","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0050","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/humupd\/dmt019","article-title":"Antithrombotic therapy for pregnancy loss","volume":"19","author":"de Jong","year":"2013","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0055","series-title":"Cochrane Database of Systematic Reviews","article-title":"Aspirin and\/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia","author":"de Jong","year":"2014"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.fertnstert.2005.12.068","article-title":"A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages","volume":"86","author":"Dolitzky","year":"2006","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/bmj.315.7099.32","article-title":"Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice","volume":"315","author":"Everett","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1469-0705.1996.07030165.x","article-title":"Sonography of pregnancies with first-trimester bleeding and a viable embryo: a study of prognostic indicators by logistic regression analysis","volume":"7","author":"Falco","year":"1996","journal-title":"Ultrasound Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/uog.2","article-title":"Sonography of pregnancies with first-trimester bleeding and a small intrauterine gestational sac without a demonstrable embryo","volume":"21","author":"Falco","year":"2003","journal-title":"Ultrasound Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00404-007-0527-x","article-title":"Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study","volume":"278","author":"Fawzy","year":"2008","journal-title":"Arch. Gynecol. Obstet"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0085","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/01.AOG.0000183604.09922.e0","article-title":"Risk factors for spontaneous abortion in early symptomatic first-trimester pregnancies","volume":"106","author":"Gracia","year":"2005","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0090","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0015-0282(02)03222-3","article-title":"Preventing adverse obstetric outcomes in women with genetic thrombophilia","volume":"78","author":"Grandone","year":"2002","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0100","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijgo.2015.09.004","article-title":"Randomized controlled study of pre-conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome","volume":"132","author":"Ismail","year":"2016","journal-title":"Int. J. Gynaecol. Obstet"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0110","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0115","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00404-015-4001-x","article-title":"Two-year outcome after recurrent first trimester miscarriages: prognostic value of the past obstetric history","volume":"293","author":"Kling","year":"2016","journal-title":"Arch. Gynecol. Obstet"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10641950109152640","article-title":"Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias","volume":"20","author":"Kupferminc","year":"2001","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1447-0756.2009.01079.x","article-title":"Recurrent pregnancy loss: a disease of inflammation and coagulation","volume":"35","author":"Kwak-Kim","year":"2009","journal-title":"J. Obstet. Gynaecol. Res"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J. Rheumatol"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-0037-1613984","article-title":"Bleeding complications associated with low molecular weight heparin prophylaxis during pregnancy","volume":"84","author":"Lindqvist","year":"2000","journal-title":"Thromb. Haemost"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0140","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/j.1538-7836.2012.04773.x","article-title":"Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort","volume":"10","author":"Lykke","year":"2012","journal-title":"J. Thromb. Haemost"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0145","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1471-0528.2009.02299.x","article-title":"Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin","volume":"116","author":"McLintock","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0155","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood-2014-11-610857","article-title":"Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial","volume":"125","author":"Pasquier","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0160","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2214\/ajr.154.3.2106217","article-title":"Prevalence and significance of subchorionic hemorrhage in threatened abortion: a sonographic study","volume":"154","author":"Pedersen","year":"1990","journal-title":"AJR Am. J. Roentgenol"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0165","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(06)69204-0","article-title":"Recurrent miscarriage","volume":"368","author":"Rai","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000292","article-title":"The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies","volume":"7","author":"Rodger","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0175","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(14)60793-5","article-title":"Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial","volume":"384","author":"Rodger","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0180","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/jth.12509","article-title":"Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study","volume":"12","author":"Rodger","year":"2014","journal-title":"J. Thromb. Haemost"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0185","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1076029616658117","article-title":"Lessons from the EThIGII trial: proper putative benefit assessment of low-molecular-weight heparin treatment in M2\/ANXA5 haplotype carriers","volume":"23","author":"Rogenhofer","year":"2017","journal-title":"Clin. Appl. Thromb. Hemost"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1471-0528.2009.02427.x","article-title":"Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review","volume":"117","author":"Saraswat","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(14)60157-4","article-title":"Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial","volume":"384","author":"Schisterman","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0205","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/M14-2062","article-title":"Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme","volume":"162","author":"Schleussner","year":"2015","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0210","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2015-12-626739","article-title":"A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia","volume":"127","author":"Skeith","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0215","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/bmj.329.7458.152","article-title":"Threatened miscarriage: evaluation and management","volume":"329","author":"Sotiriadis","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0220","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/oxfordjournals.humrep.a138137","article-title":"A prospective study of 63 couples with a history of recurrent spontaneous abortion: contributing factors and outcome of subsequent pregnancies","volume":"8","author":"Tulppala","year":"1993","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0225","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ajog.2003.09.023","article-title":"Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening study","volume":"190","author":"Weiss","year":"2004","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0230","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/aje\/kwh180","article-title":"Vaginal bleeding during pregnancy and preterm birth","volume":"160","author":"Yang","year":"2004","journal-title":"Am. J. Epidemiol"},{"key":"10.1016\/j.rbmo.2017.06.018_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000001732","article-title":"Antithrombotic treatment for recurrent miscarriage: Bayesian network meta-analysis and systematic review","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine (Baltimore)"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648317302985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648317302985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T04:02:48Z","timestamp":1569643368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648317302985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1472648317302985"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2017.06.018","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2017.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}